Escitalopram Oxalate | Annual Sales Report | Pharmacompass.com

Please Wait

Applying Filters...

Escitalopram Oxalate

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

88 API Suppliers, 33 USDMF, 17 CEP/COS, 10 JDMF, 17 EU WC, 31 KDMF, 16 NDC API, 42 Listed Suppliers, $ API Reference Price

DEVELOPMENTS

40 Drugs in Development

40 Drugs in Development

INTERMEDIATES

25 Intermediate Suppliers

25 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

908 FDF Dossiers, 84 FDA Orange Book, 567 Europe, 51 Canada, 78 Australia, 44 South Africa, 84 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TABLET;ORAL - EQ 10MG BASE, TABLET;ORAL - EQ 20MG BASE, TABLET;ORAL - EQ 5MG BASE, SOLUTION;ORAL - EQ 5MG BASE/5ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

RELATED EXCIPIENT COMPANIES

2 EUROAPI, 1 Minakem, 3 Rochem International Inc, 18 SPI Pharma, 2 Boai NKY Pharmaceuticals Ltd, 6 Gangwal Healthcare, 7 Nanjing Well Pharmaceutical, 1 Pfanstiehl, 3 Kirsch Pharma, 1 ACG Worldwide, 9 Actylis, 1 Aeon Procare, 7 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 2 Ashland, 21 BASF, 1 CD Formulation, 2 Clariant, 10 Corel Pharma Chem, 5 DFE Pharma, 1 Esteem Industries, 2 Finar, 10 Gangwal Chemicals, 1 Gloria Interchem, 4 Ideal Cures, 4 Ingredion Pharma Solutions, 20 Kerry, 3 Keval Exports, 4 Kima Chemical, 6 Lonza Capsugel, 16 Microlex e.U, 1 Nanjing Bold Chemical, 1 Neelkanth MineChem, 2 Nitika Pharmaceutical Specialities, 2 Nomisma Healthcare, 2 Novo Excipients, 2 Pharmatrans-Sanaq, 7 Pluviaendo, 3 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 1 Qualicaps, 27 Roquette, 13 Seppic, 6 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 2 Shijiazhuang Huaxu Pharmaceutical, 10 Sigachi Industries, 3 Silverline Chemicals, 3 The Dow Chemical Company, 1 Valens Pharmachem, 3 Vasa Pharmachem, 1 Zhejiang Huakang Pharmaceutical

EXCIPIENTS BY APPLICATIONS

69 Fillers, Diluents & Binders, 44 Coating Systems & Additives, 31 Direct Compression, 31 Thickeners and Stabilizers, 28 Solubilizers, 25 Granulation, 24 Controlled & Modified Release, 24 Parenteral, 23 Film Formers & Plasticizers, 23 Disintegrants & Superdisintegrants, 20 Taste Masking, 19 Topical, 19 Chewable & Orodispersible Aids, 13 Lubricants & Glidants, 13 Co-Processed Excipients, 8 Emulsifying Agents, 8 Rheology Modifiers, 6 API Stability Enhancers, 5 Surfactant & Foaming Agents, 5 Empty Capsules, 4 Vegetarian Capsules, 2 Coloring Agents, 1 Soft Gelatin

DIGITAL CONTENT

9 News #PharmaBuzz

9 News #PharmaBuzz

GLOBAL SALES INFORMATION

19 US Medicaid Prescriptions, 73 Regulatory FDF Prices, 6 Annual Reports

MARKET PLACE

16 APIs, 2 FDF Dossiers, 1 Intermediates

PATENTS & EXCLUSIVITIES

4 US Exclusivities, 8 Health Canada Patents

REF. STANDARDS & IMPURITIES

1 EDQM, 4 USP, 5 Others

$ Xls

Filters

Filters

FILTER :

filter Product Reset all filters

6 All

01 6Cipralex/Lexapro

List of Suppliers

Product Main Page

01

Brand Name : Cipralex/Lexapro

euroPLX 90 Lisbon

Contact Supplier

Contact Supplier

Digital Content

Lundbeck CDM delivers end-to-end API and drug product solutions from development to commercial scale.

Escitalopram

Main Therapeutic Indication : CNS & Anesthesia

Currency : USD

2020 Revenue in Millions : 387

2019 Revenue in Millions : 376

Growth (%) : 3

Product Web Link

Digital Content

Corporate PDF

02

Brand Name : Cipralex/Lexapro

euroPLX 90 Lisbon

Contact Supplier

Contact Supplier

Digital Content

Lundbeck CDM delivers end-to-end API and drug product solutions from development to commercial scale.

Escitalopram

Main Therapeutic Indication : Neurology

Currency : USD

2021 Revenue in Millions : 358

2020 Revenue in Millions : 381

Growth (%) : -1

Product Web Link

Digital Content

Corporate PDF

03

Brand Name : Cipralex/Lexapro

euroPLX 90 Lisbon

Contact Supplier

Contact Supplier

Digital Content

Lundbeck CDM delivers end-to-end API and drug product solutions from development to commercial scale.

Escitalopram

Main Therapeutic Indication : Neurology

Currency : USD

2022 Revenue in Millions : 340

2021 Revenue in Millions : 358

Growth (%) : -5

Product Web Link

Digital Content

Corporate PDF

04

Brand Name : Cipralex/Lexapro

euroPLX 90 Lisbon

Contact Supplier

Contact Supplier

Digital Content

Lundbeck CDM delivers end-to-end API and drug product solutions from development to commercial scale.

Escitalopram

Main Therapeutic Indication : Neurology

Currency : USD

2023 Revenue in Millions : 308

2022 Revenue in Millions : 340

Growth (%) : -10

Product Web Link

Digital Content

Corporate PDF

05

Brand Name : Cipralex/Lexapro

euroPLX 90 Lisbon

Contact Supplier

Contact Supplier

Digital Content

Lundbeck CDM delivers end-to-end API and drug product solutions from development to commercial scale.

Escitalopram

Main Therapeutic Indication : Neurology

Currency : USD

2024 Revenue in Millions : 284

2023 Revenue in Millions : 308

Growth (%) : -8

Product Web Link

Digital Content

Corporate PDF

06

Brand Name : Cipralex/Lexapro

euroPLX 90 Lisbon

Contact Supplier

Contact Supplier

Digital Content

Lundbeck CDM delivers end-to-end API and drug product solutions from development to commercial scale.

Escitalopram

Main Therapeutic Indication : CNS & Anesthesia

Currency : USD

2019 Revenue in Millions : 347

2018 Revenue in Millions : 339

Growth (%) : 3

Product Web Link

Digital Content

Corporate PDF

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.